UnitedHealth Group Incorporated $UNH Shares Sold by Fifth Third Bancorp

Posted by Brian Himes on Nov 12th, 2026

Fifth Third Bancorp reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 499,144 shares of the healthcare conglomerate’s stock after selling 9,541 shares during the period. Fifth Third Bancorp’s holdings in UnitedHealth Group were worth $183,226,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Maryland State Retirement & Pension System bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $20,248,000. Machina Capital S.A.S. bought a new position in UnitedHealth Group during the third quarter valued at approximately $7,497,000. DSG Capital Advisors LLC raised its position in UnitedHealth Group by 0.9% during the third quarter. DSG Capital Advisors LLC now owns 62,565 shares of the healthcare conglomerate’s stock valued at $22,966,000 after acquiring an additional 568 shares in the last quarter. Silver Grove Financial Group Inc. lifted its stake in UnitedHealth Group by 5.7% in the third quarter. Silver Grove Financial Group Inc. now owns 1,165 shares of the healthcare conglomerate’s stock valued at $428,000 after acquiring an additional 63 shares during the last quarter. Finally, Illinois Municipal Retirement Fund grew its position in UnitedHealth Group by 7.8% in the third quarter. Illinois Municipal Retirement Fund now owns 61,044 shares of the healthcare conglomerate’s stock worth $22,408,000 after acquiring an additional 4,395 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 0.5%

NYSE:UNH opened at $403.14 on Thursday. The company’s 50 day moving average is $391.12 and its 200-day moving average is $364.76. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The firm has a market cap of $361.22 billion, a price-to-earnings ratio of 19.85, a P/E/G ratio of 1.47 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same period in the prior year, the firm earned $2.59 EPS. UnitedHealth Group’s quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is currently 53.00%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. Deutsche Bank increased their price target on shares of UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a research note on Friday, July 17th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Erste Group Bank downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. New Street Research set a $402.00 target price on UnitedHealth Group in a report on Friday, October 9th. Finally, Barclays reduced their price target on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating for the company in a research report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

Check Out Our Latest Stock Report on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.